I was going to ask the same question myself,
It is very hard to work out what ±35% with a 15% contingency applied to capital costs relates to when the study has no figures,
I wonder why they have left out the most important figures ?
Has anyone tried to contact Will or the office, It should be open by now.
Ann: Plomosas Scoping Study Completed with Positive Results, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
